Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy

被引：0
|
作者：
Ohtsuka, T. [1 ]
Uetani, T. [1 ]
Saito, M. [1 ]
Inaba, S. [1 ]
Nagai, T. [1 ]
Nishimura, K. [1 ]
Kurata, A. [1 ]
Ogimoto, A. [1 ]
Okayama, H. [1 ]
Higaki, J. [1 ]
机构：
[1] Ehime Univ, Dept Internal Med 2, Matsuyama, Ehime 790, Japan
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：786 / 786
页数：1
相关论文
共 50 条
  • [31] Prognostic value of serum indoxyl sulfate in patients with nonischemic dilated cardiomyopathy
    Shimazu, S.
    Hirashiki, A.
    Okumura, T.
    Okamoto, R.
    Yamada, T.
    Takeshita, K.
    Cheng, X.
    Kondo, T.
    Niwa, T.
    Murohara, T.
    EUROPEAN HEART JOURNAL, 2012, 33 : 649 - 649
  • [32] A Novel Risk Stratification Score for Sudden Cardiac Death Prediction in Middle-Aged, Nonischemic Dilated Cardiomyopathy Patients: The ESTIMATED Score
    Li, Xiaofei
    Fan, Xiaohan
    Li, Shuang
    Sun, Wei
    Shivkumar, Kalyanam
    Zhao, Shihua
    Lu, Minjie
    Yao, Yan
    CANADIAN JOURNAL OF CARDIOLOGY, 2020, 36 (07) : 1121 - 1129
  • [33] Cholesterol metabolism as a prognostic marker in patients with mildly symptomatic nonischemic dilated cardiomyopathy
    Sawamura, Akinori
    Okumura, Takahiro
    Hiraiwa, Hiroaki
    Aoki, Soichiro
    Kondo, Toru
    Ichii, Takeo
    Furusawa, Kenji
    Watanabe, Naoki
    Kano, Naoaki
    Fukaya, Kenji
    Morimoto, Ryota
    Bando, Yasuko K.
    Murohara, Toyoaki
    JOURNAL OF CARDIOLOGY, 2017, 69 (5-6) : 888 - 894
  • [34] Comparison of levels of matrix metalloproteinase-2 and-3 in patients with ischemic cardiomyopathy versus nonischemic cardiomyopathy
    Tziakas, DN
    Chalikias, GK
    Papaioakeim, M
    Hatzinikolaou, EI
    Stakos, DA
    Tentes, IK
    Papanas, N
    Kortsaris, A
    Maltezos, E
    Hatseras, DI
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (10): : 1449 - 1451
  • [35] Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: A marker of cardiac dilatation
    Hanumanth K. Reddy
    Imam E. Tjahja
    Scott E. Campbell
    Joseph S. Janicki
    Melvin R. Hayden
    Suresh C. Tyagi
    Molecular and Cellular Biochemistry, 2004, 264 : 183 - 191
  • [36] Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: A marker of cardiac dilatation
    Reddy, HK
    Tjahja, IE
    Campbell, SE
    Janicki, JS
    Hayden, MR
    Tyagi, SC
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 264 (1-2) : 183 - 191
  • [37] Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy
    Anghel, Larisa
    Sascau, Radu
    Zota, Ioana Madalina
    Statescu, Cristian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [38] Use of novel HRV-parameters for risk stratification in patients with dilated cardiomyopathy
    Demming, T.
    Weidtmann, B.
    Frey, N.
    Bonnemeier, H.
    EUROPEAN HEART JOURNAL, 2010, 31 : 268 - 268
  • [39] CIRCULATING MATRIX METALLOPROTEINASE-3 IS ASSOCIATED WITH VENTRICULAR ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY
    Zachariah, Justin
    Colan, Steven D.
    Lang, Peter
    Triedman, John K.
    Alexander, Mark E.
    Walsh, Edward P.
    Berul, Charles I.
    Cecchin, Frank
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E454 - E454
  • [40] Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis
    Romi, Fredrik R.
    Gilhus, Nils Erik
    Luckman, Steven P.
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 195 (1-2) : 96 - 99
12345